This 973-page report contains 153 tables and provides a comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies. The report is available by section, and can be customized to specific information needs and budget.
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient.
Market Segmentation Analysis
- Review of the ER, OR and ICU market segments, including their dynamics, trends, structure, size, growth and major suppliers.
- Five-year test volume and sales forecasts for chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:
- Emergency Rooms
- Operating/Recovery Suites
and test category:
- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Flow Cytometry
- Drugs of Abuse
- Endocrine Function
- Tumor Markers
Sales and Market Share Analysis
- Sales and market shares of major reagent and instrument suppliers.
Current and Emerging Products
- Analysis of over 130 diagnostic procedures.
- Review of leading POC chemistry, immunoassay, hematology and coagulation analyzers,
both currently marketed and those in development, including their operating characteristics, features and selling prices.
- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.
- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and proprietary data files.
Contains 973 pages and 153 tables
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Decode Genetics
- Diagnostica Stago
- Eiken Chemical
- EKF Diagnostics
- Helena Laboratories
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- Leica Biosystems
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Sekisui Diagnostics
- Siemens Healthineers
- Takara Bio
- Thermo Fisher